Reaction
Migraine Without Aura reporting signals
As of the last recalculation, Migraine Without Aura appears in 295 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is RIZATRIPTAN BENZOATE (PRR 164.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Rizatriptan Benzoate | 22 | 164.8 | 165.2 |
| Naltrexone Hydrochloride And Bupropion Hydrochloride | 18 | 158.6 | 158.9 |
| Sumatriptan Succinate | 30 | 93.1 | 93.2 |
| Ketoprofen | 13 | 73.1 | 73.2 |
| Naltrexone | 20 | 49.0 | 49.1 |
| Sumatriptan | 23 | 46.1 | 46.1 |
| Fremanezumab-Vfrm | 5 | 31.2 | 31.3 |
| Erenumab-Aooe | 17 | 23.0 | 23.0 |
| Rimegepant Sulfate | 4 | 22.6 | 22.6 |
| Onabotulinumtoxina | 22 | 21.7 | 21.7 |
| Galcanezumab-Gnlm | 4 | 9.1 | 9.1 |